SBM 2014 Annual Meeting Rapid Abstracts and Registration Information

Society of Behavioral Medicine

35th Annual Meeting and Scientific Sessions
April 23-26, 2014
Philadelphia, PA

Rapid Communication Poster Abstract Submission Site Opens
Click Here for Submission Information

Deadline:Tuesday, January 7, 2014

Abstracts are now being accepted for Rapid Communication poster presentations, which allow authors a chance to present late-breaking findings, data and other information in the field of behavioral medicine at SBM’s 35th Annual Meeting and Scientific Sessions.

Early Bird Registration Now Open

With innovative workshops, high profile keynote sessions, compelling master lecturers and a wide variety of behavioral medicine focused seminars, panel discussions, paper and poster sessions, the 2014 SBM Annual Meeting will provide invaluable education and networking opportunities for all attendees. The conference will be held at the centrally-located Philadelphia Marriott Downtown in historic Philadelphia, Pennsylvania. Early bird registration, which offers discounted registration fees, is open until March 25, 2014.

Embodying the meeting theme, "Behavior Matters: The Impact and Reach of Behavioral Medicine,” the conference will explore the impact of behavioral medicine on health and health care across diverse settings, populations, and cultures. Presentations will address thematic areas of the conference as well as other behavioral medicine topics.

Plenary Sessions at the 35th SBM Annual Meeting

Sherry A. Glied, PhD

The Program Planning Committee is pleased to announce that confirmed plenary speakers include the individuals noted below. Additional speakers will be profiled in future emails.

Keynote: The Affordable Care Act and Behavioral Medicine

Speaker: Sherry A. Glied, PhD; Dean and Professor of Public Service, Robert F. Wagner Graduate School of Public Service, New York University

This talk will examine the history and structure of the Affordable Care Act, focusing on how findings from the field of behavioral medicine have been incorporated in the Act. The talk will also discuss new research opportunities and needs presented by implementation of the Act.

Colleen M. McBride, PhD

Keynote: Prospects for Breakthroughs in Behavioral Science: The Role of Genomics

Speaker: Colleen M. McBride, PhD; Branch Chief, National Human Genome Research Institute

It is being suggested that the burgeoning arena of genomic discovery will bring breakthroughs in disease prevention and medical care. To date, the vision for "translation research” related to behavioral medicine largely has been restricted to considering the effects of genomic risk information on motivation for behavior change. In this keynote, Dr. McBride will suggest a broadened agenda for research that considers how advances in genomics and epigenetics might be used to improve the science of behavior change.

Karina W. Davidson, PhD

Distinguished Scientist Master Lecture: Behavior Matters: Innovative Intervention Strategies to Decrease Readmissions through Improving Patient, Provider & System Behavior

Speaker:Karina W. Davidson, PhD; Director, Center for Behavioral Cardiovascular Health, Columbia University

In describing the many ways that behavior can matter, I provide an overview of the behavioral interventions that we are rapidly developing, refining, and testing to decrease preventable 30-day readmissions. The Affordable Care Act requires that 30 day readmissions associated with many chronic health conditions be reduced, and behavioral medicine can play a strong and vigorous role in this important public health initiative.

Carl W. Lejuez, PhD

Master Lecture: Vulnerabilities Underlying the Development and Maintenance of Substance Use Problems

Speaker:Carl W. Lejuez, PhD; Director, Center for Addictions, Personality, and Emotion Research, University of Maryland

Despite substantial testing of behavioral and pharmacological treatments for substance use disorders, progress towards identifying efficacious interventions has been slow. Advances in basic and clinical research have highlighted the importance of understanding processes that may underlie the development and maintenance of substance use. This presentation will review a body of research focused on biological (e.g., genes and neural targets), personality, and environmental factors that contribute to one’s risk for problematic substance use and how the improvement in understanding these factors can contribute to novel treatment development efforts.